Best Practices for convening a GRAS Panel
USA
Dec 21, 2022
The Food and Drug Administration (FDA) published Guidance for Industry: Best Practices for convening a GRAS Panel.
This guidance document is intended to provide recommendations on best practices for convening a “GRAS panel.” By “GRAS,” mean “generally recognized as safe.” See section II.A for a discussion of the GRAS provision of the Federal Food, Drug, and Cosmetic Act (FD&C Act). By “GRAS panel,” mean a panel of qualified experts who independently evaluate whether the available scientific data, information, and methods establish that a substance is safe under the conditions of its intended use in human food or animal food as part of an evaluation of whether adding that substance to food is lawful under the GRAS provision of the FD&C Act.
For further information (in English), click on the Link
Check the full text of the documents (in English), click on the Link